InvestEU operations - list

The Sub-Projects under this Framework Operation aim to support financial intermediaries that should enhance access to finance for sustainable enterprises and support investments contributing to the green and sustainable transformation of the European economy.

The framework operation aims at providing support to innovation and digitalisation driven SMEs and Small Mid-Caps in Greece.

The present operation concerns the deployment of renewable energy (solar PV) and energy storage (battery energy storage) in selected countries in the EU, primarily in Greece and Italy. The promoter is Mytilineos S.A., a Greek company operating in the Metals and Energy Sectors.

The Framework Operation will aim to support Sub-Projects aiming at improving the competitiveness of SMEs and promoting private investments and exports of the Greek companies, in line with the Recovery and Resilience Plan for Greece.

Sub-Projects under this Framework Operation aim tosupport financial intermediaries that should enhance access to finance for sustainable enterprises and support investments contributing to the green transition to a more environmentally sustainable and climate resilient economy.

Under the Bulgaria Member State Compartment, the EU will provide to the EIF an EU guarantee to cover financing operations and implementation costs of Member State Compartment in Bulgaria.

Under the Bulgaria Member State Compartment, the EU will provide to the EIF an EU guarantee to cover financing operations and implementation costs of Member State Compartment in Bulgaria.

The Framework Operation will support Sub-Projects aiming to enhance access to finance for sustainable enterprises and support investments contributing to the green and sustainable transformation of the Greek economy.

The loan will provide direct equity-type financing supported by the Invest EU mandate to finance RD&I activities of an innovative Danish biopharmaceutical company for the development of its diversified portfolio of novel preclinical and clinical-stage peptide-based product therapeutics...